Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Monocytic, Acute × ixazomib × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 24 Waldenstrom Macroglobulinemia 3 Immunoglobulin Light-chain Amyloidosis 3 Recurrence 2 Lymphoma, Mantle-Cell 2 Smoldering Multiple Myeloma 1 Sarcoma, Kaposi 1 Proteostasis Deficiencies 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm, Residual 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematologic Neoplasms 1 Carcinoma, Transitional Cell 1 Amyloidosis 1

Interventions

Cytarabine 5 Whole-Body Irradiation 3 Peripheral Blood Stem Cell Transplantation 3 Injections 3 Biopsy 3 Azacitidine 3 venetoclax 2 pegylated granulocyte colony-stimulating factor 2 Tacrolimus 2 Sirolimus 2 Idarubicin 2 Gemtuzumab 2 Decitabine 2 Daunorubicin 2 Cyclophosphamide 2 Cladribine 2 Busulfan 2 Bone Marrow Transplantation 2 ruxolitinib 1 fludarabine phosphate 1 fludarabine 1 fedratinib 1 aldesleukin 1 Thiotepa 1 Spinal Puncture 1 Specimen Handling 1 Social Determinants of Health 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mycophenolic Acid 1 Mitoxantrone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡